Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-25 @ 4:44 PM
Study NCT ID:
NCT00383903
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2006-10-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-03
First Submit QC Date:
None
Study First Post Date:
2006-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-14
Last Update Post Date:
2016-09-15
Last Update Post Date Type:
ESTIMATED